These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 10481945)

  • 1. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.
    Asch HL; Winston JS; Edge SB; Stomper PC; Asch BB
    Breast Cancer Res Treat; 1999 May; 55(2):179-88. PubMed ID: 10481945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma.
    Simpson JF; O'Malley F; Dupont WD; Page DL
    Cancer; 1994 May; 73(9):2352-8. PubMed ID: 7513249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of Hsp-27 and HER-2/neu in in situ and invasive ductal breast carcinomas.
    Storm FK; Gilchrist KW; Warner TF; Mahvi DM
    Ann Surg Oncol; 1995 Jan; 2(1):43-8. PubMed ID: 7530588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma in situ of the breast: histological classification and genetic alterations.
    van de Vijver MJ
    Recent Results Cancer Res; 1998; 152():123-34. PubMed ID: 9928552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast.
    Done SJ; Eskandarian S; Bull S; Redston M; Andrulis IL
    J Natl Cancer Inst; 2001 May; 93(9):700-4. PubMed ID: 11333292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
    Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of gelsolin correlates with the progression to breast carcinoma.
    Winston JS; Asch HL; Zhang PJ; Edge SB; Hyland A; Asch BB
    Breast Cancer Res Treat; 2001 Jan; 65(1):11-21. PubMed ID: 11245335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
    Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
    Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2, p16 and Ki67 expression in DCIS, microinvasive and early invasive breast carcinoma with extensive intraductal component.
    Bartova M; Ondrias F; Muy-Kheng T; Kastner M; Singer Ch; Pohlodek K
    Bratisl Lek Listy; 2014; 115(7):445-51. PubMed ID: 25077370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.
    Seth A; Kitching R; Landberg G; Xu J; Zubovits J; Burger AM
    Anticancer Res; 2003; 23(3A):2043-51. PubMed ID: 12894577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade.
    Sowter HM; Ferguson M; Pym C; Watson P; Fox SB; Han C; Harris AL
    J Pathol; 2003 Dec; 201(4):573-80. PubMed ID: 14648660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
    Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F
    Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal breast cancer: evaluation of histology and biological marker expression.
    Dublin EA; Millis RR; Smith P; Bobrow LG
    Br J Cancer; 1999 Jul; 80(10):1608-16. PubMed ID: 10408407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.
    Mack L; Kerkvliet N; Doig G; O'Malley FP
    Hum Pathol; 1997 Aug; 28(8):974-9. PubMed ID: 9269835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
    Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
    Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
    Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
    Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of ductal carcinoma in-situ of breast and its correlation with the grade of associated invasive component.
    Konar K; Chatterjee U; Dutta SK
    Indian J Pathol Microbiol; 2001 Jul; 44(3):297-300. PubMed ID: 12024916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.